Full Text
PAR6- ECONOMIC ANALYSIS OF NOVEL DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS (DMARDS) FOR RHEUMATOID ARTHRITIS (RA) PATIENTS IN A MANAGED CARE SETTING

Abstract

Authors

AO DSouza C Crivera JJ Doyle

Back to Volume 6, Issue 3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×